Vivimed Labs Ltd.
Snapshot View

9.24 +0.24 ▲2.7%

25 November 2022, 04:01:00 PM
Volume: 30,130

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vivimedlabs.com
Market Cap 76.70 Cr.
Enterprise Value(EV) 440.99 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -10.40 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 34.02 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.27 Calculated using Price: 9.24
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 8.29 Cr. 82,913,915 Shares
FaceValue 2
Company Profile
Vivimed Labs Ltd was originally incorporated as Emgi Pharmaceuticals & Chemicals Private Limited on 22-09-1988 with Registrar of Companies of Karnataka, Bangalore and subsequently converted into a public limited company on April 21, 1994. The name of the company has been changed to Vivimed Labs Limited on April 22,1997.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.67%
1 Week
-1.39%
1 Month
-3.35%
3 Month
-4.15%
6 Month
-31.04%
1 Year
-49.09%
2 Year
-47.05%
5 Year
-92.18%
10 Year
-86.05%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 26.70 23.34 14.81 14.90 16.50 35.18 9.76 7.95 -20.75
Return on Capital Employed (%) 14.29 13.83 11.93 10.91 11.93 21.86 9.04 7.03 -2.69
Return on Assets (%) 6.69 5.83 3.90 3.86 4.25 10.44 3.43 2.44 -4.83

Balance Sheet View Details >>

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03* Rs. Cr. 2021-03* Rs. Cr. 2022-03* Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 559 585 734 1,226 944 835 432 432 364 320
Non Curr. Liab. 538 561 504 357 490 591 516 516 528 534
Curr. Liab. 801 897 817 790 889 770 341 341 374 394
Minority Int. 12
Equity & Liab. 1,898 2,044 2,055 2,386 2,322 2,196 1,289 1,289 1,266 1,248
Non Curr. Assets 906 911 961 1,104 1,092 1,221 761 761 759 755
Curr. Assets 992 1,133 1,094 1,282 1,231 975 529 529 507 493
Misc. Exp. not W/O 0 0
Total Assets 1,898 2,044 2,055 2,386 2,322 2,196 1,289 1,289 1,266 1,248

Profit Loss View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 668 1,109 1,351 1,380 1,346 1,462 1,186 1,315 1,059 212
Other Income 3 26 36 8 24 8 24 34 12 0
Total Income 671 1,135 1,387 1,388 1,369 1,470 1,209 1,349 1,071 212
Total Expenditure -538 -928 -1,166 -1,158 -1,123 -1,057 -985 -1,146 -1,052 -238
PBIDT 133 207 220 230 247 413 224 203 19 -26
Interest -28 -50 -67 -86 -85 -68 -82 -70 -61 -40
Depreciation -27 -59 -66 -66 -61 -58 -56 -67 -67 -18
Taxation -15 -14 -20 -5 -16 -73 -10 -9 0 -3
Exceptional Items
PAT 63 84 66 72 84 214 76 57 -109 -86
Minority Interest 2
Share Associate
Other Related Items
Consolidated Net Profit 63 84 66 72 84 214 78 57 -109 -86
Adjusted EPS 9 10 8 9 10 26 9 7 -13 -10

Cash Flow View Details >>

Particulars 10 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 24 45 90 -118 140 154 58 21 422 80
Cash Fr. Inv. -72 -424 -170 -291 -107 -190 -68 -164 -89 -196
Cash Fr. Finan. 54 404 67 419 -42 41 35 186 -338 72
Net Change 5 25 -12 11 -8 4 25 44 -5 -44
Cash & Cash Eqvt 11 36 24 35 27 31 55 99 95 50

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 32.79 32.79 28.57 28.57 28.57 28.57 21.98 20.96 20.96
Public 67.21 67.21 71.43 71.43 71.43 71.43 78.02 79.04 79.04
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 60.09 60.09 54.20 54.20 54.20 54.20 40.02 37.11 37.11

Announcements View Details >>

Fri, 18 Nov 2022
Board Meeting Outcome for Revised - Outcome Of The Meeting Of The Board Of Directors Of The Company
Revised - Outcome of the Meeting of the Board of Directors of the Company
In relation to Board meeting end time
Mon, 14 Nov 2022
Outcome Of The Meeting Of The Board Of Directors Of The Company
Outcome of the Meeting of the Board of Directors of the Company
Thu, 27 Oct 2022
Board Meeting Intimation for Notice Of Board Meeting / Closure Of Trading Window-Reg
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve Notice of Board Meeting / Closure of Trading Window

Technical Scans View Details >>

Fri, 25 Nov 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Closing Above Previous High Closing Above Previous High

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Vivimed Labs Ltd.

What is Vivimed Labs share price?

Can I buy Vivimed Labs shares now?

What is the Market Cap of Vivimed Labs?

What are the key metrics to analyse Vivimed Labs?

What is the 52 Week High and Low of Vivimed Labs?

What is the trend of Vivimed Labs share price?